ArisGlobal Announces Continued Growth with New Global Offices
Organization Opens New Offices in Belgium and Ireland
STAMFORD, CT—JUNE 25, 2012—ArisGlobal, a provider of solutions to the life science industry, announced the opening of two new offices in Antwerp, Belgium and Dublin, Ireland.
These new offices will allow the company to continue its growth and expansion in several product areas including pharmacovigilance and risk management, clinical data management and operations, regulatory affairs, and medical information management.
“We continue to grow with the addition of new customers and the development of new products and offerings. This expansion has created the need for an even broader global presence and new space in several regions of the world,” commented Vice President of European Operations, Simon Sparkes. “This expansion will help us to deliver added value to our customers and further execute on our vision of a suite of integrated life science software and services meeting the diverse needs of organizations around the world.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
